Switzerland· 69945001
Brukinsa 160 mg, Filmtabletten
A zanubrutinib product containing zanubrutinibum, registered in Switzerland by BeOne Medicines I GmbH and dispensed under Swissmedic category A. The same ATC class is registered in 15 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Zanubrutinib is registered in 15 of 19 countries.
Countries holding a registration under ATC L01EL03 (zanubrutinib), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Zanubrutinib · ATC L01EL03
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of zanubrutinib costs, country by country.
Normalised to the WHO defined daily dose (0.32 g), so markets compare like for like.
- Switzerland: $188.14 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Zanubrutinib · price per daily dose (0.32 g)
USD · FX 28 Sept 2026
- CH Switzerland$188.14
The record
At a glance
Swissmedic (Switzerland)- Active substance
- zanubrutinibum
- Manufacturer
- BeOne Medicines I GmbH
- Country
- Switzerland (CH)
- ATC code
- L01EL03
- ATC class
- Zanubrutinib
- Defined daily dose
- 0.32 g, O
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
217 interactions on record for zanubrutinib.
Graded by severity as the source publishes them — 140 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zanubrutinib · interactions on record
217 records
- 140 severe
- 77 moderate
Most severe, free to view
- AprepitantA04AD12severe
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Zanubrutinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBRUKINSABeOne Medicines USA, Inc.
- CzechiaBRUKINSABeOne Medicines Ireland Limited, Dublin
- SpainBRUKINSA 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULABeone Medicines Ireland Limited
- FinlandBRUKINSABeOne Medicines Ireland Limited
- IrelandBRUKINSA 160 mg film-coated tabletsBeiGene Ireland Limited
- BelgiumBrukinsa 160 mgBeOne Medicines Ireland
- NetherlandsBRUKINSA 160 mg filmomhulde tablettenBeiGene Ireland Limited
- PolandBrukinsaBeiGene Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Brukinsa
- Norway · Brukinsa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a88706fd-818b-4858-a5f6-e14741583b7a GET /v1/drugs/a88706fd-818b-4858-a5f6-e14741583b7a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about zanubrutinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.